The Call of Commerce: Former Academics Cite Advantages in Industry

The excitement of turning theory into therapeutics...The opportunity to focus on research, without the distractions of committee work...The prospect of advancing one's career without navigating the tenure process...The chance to collaborate, rather than carve an individual niche...The potential for greater remuneration--if the science proves marketable... A host of reasons prompts scientists to ponder switching from academia to industry--whether as start-up employee, biotech entrepreneur, or B

Written byPaul Smaglik
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

A host of reasons prompts scientists to ponder switching from academia to industry--whether as start-up employee, biotech entrepreneur, or Big Pharma scientific director. These reasons tend to be unique to each person's situation. But two underlying forces may be at the roots of these personal choices, which both surveys and stories indicate more scientists are making.

Rolf F. Lehming, director of the integrated studies program at the National Science Foundation's division of science resources studies, thinks a "push and pull" phenomenon has driven the trend. The "push," posits Lehming, comes from academic hiring-- or lack thereof. Academic hiring has slowed considerably since a boom beginning in the 1960s. "In the early '70s, academia employed 55 percent of all doctoral scientists and engineers in the [United States]," Lehming says. "That's now down to about 46 percent." The rate of hiring new, full-time professors in universities flattened in the '90s--with only enough ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery